DE69315257D1 - Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen - Google Patents

Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen

Info

Publication number
DE69315257D1
DE69315257D1 DE69315257T DE69315257T DE69315257D1 DE 69315257 D1 DE69315257 D1 DE 69315257D1 DE 69315257 T DE69315257 T DE 69315257T DE 69315257 T DE69315257 T DE 69315257T DE 69315257 D1 DE69315257 D1 DE 69315257D1
Authority
DE
Germany
Prior art keywords
simethicon
treatment
gastrointestinal disorders
medicines containing
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69315257T
Other languages
English (en)
Other versions
DE69315257T2 (de
Inventor
Charles A Stevens
Michael R Hoy
Edward J Roche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26715151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69315257(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Application granted granted Critical
Publication of DE69315257D1 publication Critical patent/DE69315257D1/de
Publication of DE69315257T2 publication Critical patent/DE69315257T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
DE69315257T 1992-05-21 1993-05-20 Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen Expired - Lifetime DE69315257T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88720792A 1992-05-21 1992-05-21
US3839793A 1993-03-29 1993-03-29

Publications (2)

Publication Number Publication Date
DE69315257D1 true DE69315257D1 (de) 1998-01-02
DE69315257T2 DE69315257T2 (de) 1998-05-14

Family

ID=26715151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69315257T Expired - Lifetime DE69315257T2 (de) 1992-05-21 1993-05-20 Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen

Country Status (7)

Country Link
US (4) US5679376A (de)
EP (1) EP0571217B1 (de)
BR (1) BR1100507A (de)
CA (1) CA2096575C (de)
DE (1) DE69315257T2 (de)
ES (1) ES2112387T3 (de)
GR (1) GR1002332B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177125B1 (en) * 1994-08-03 2001-01-23 Gunter M. Voss Method of producing coated tablets
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6100245A (en) * 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
AU781718B2 (en) * 1999-11-02 2005-06-09 Depomed, Inc. Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
SK287819B6 (sk) * 2000-06-23 2011-11-04 Bioprojet Dry powder pharmaceutical composition for oral administration
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6669271B2 (en) * 2001-06-22 2003-12-30 East Manufacturing Corporation Smooth side body structure and method
JP2005509605A (ja) 2001-09-28 2005-04-14 マクニール−ピーピーシー・インコーポレイテッド 可食性組成物と可食性外皮を含む剤形
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US7378081B2 (en) * 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
US20050180920A1 (en) * 2003-01-29 2005-08-18 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7096533B2 (en) * 2004-06-12 2006-08-29 Kruegar International, Inc. Locking roller for an article of furniture
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
EP1992345A4 (de) * 2006-03-09 2010-07-28 Espinoza Abdala Leopoldo De Je Synerge kombination von h2-rezeptor-hemmern, einem inerten silikon und einem hydroxymagnesium-aluminat-komplex
US7976872B2 (en) * 2006-07-24 2011-07-12 L. Perrigo Company Method for distributing a pharmaceutically active compound in an excipient
US7754041B2 (en) * 2006-07-31 2010-07-13 3M Innovative Properties Company Pleated filter with bimodal monolayer monocomponent media
US7662373B2 (en) * 2006-09-18 2010-02-16 Thompson Ronald J Method and composition of a medicament to decrease the adverse events of Olistat, an oral lipase inhibitor
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone
KR20110079641A (ko) 2008-09-09 2011-07-07 아스트라제네카 아베 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
CA2860231A1 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
US20180311201A1 (en) 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
WO2017106812A1 (en) 2015-12-19 2017-06-22 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
CA3076413A1 (en) 2017-09-29 2019-04-04 Johnson & Johnson Consumer Inc. Solid simethicone particles and dosage form thereof
BR112020016884A2 (pt) * 2018-02-26 2020-12-15 R.P. Scherer Technologies, Llc Forma de dosagem farmacêutica para uma emulsão de simeticona e loperamida
GR1009632B (el) * 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος
WO2023089432A1 (en) * 2021-11-16 2023-05-25 Johnson & Johnson Consumer Inc. Customizable dosage forms containing simethicone
WO2023187225A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral products

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
NL7504704A (nl) * 1974-05-16 1975-11-18 Hoffmann La Roche Geneesmiddel.
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
CA1139221A (en) * 1978-10-10 1983-01-11 Vijay B. Surpuriya Antacid compositions
US4198390A (en) * 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4857324A (en) * 1985-10-08 1989-08-15 American Home Products Corporation (Del.) Exogenously acidified antacid compositions having cytoprotective properties
EP0294933B1 (de) * 1987-05-08 1992-03-11 Smith Kline & French Laboratories Limited Pharmazeutische Zusammensetzungen
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
US5275819A (en) * 1989-02-06 1994-01-04 Amer Particle Technologies Inc. Drug loaded pollen grains with an outer coating for pulsed delivery
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
IN171919B (de) * 1989-11-01 1993-02-06 Mcneil Ppc Inc
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5116847A (en) * 1991-01-25 1992-05-26 The Procter & Gamble Company Use of loperamide and related compounds for treatment of respiratory disease symptoms
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
US5447918A (en) * 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids

Also Published As

Publication number Publication date
EP0571217A2 (de) 1993-11-24
BR1100507A (pt) 2002-04-02
GR1002332B (el) 1996-05-16
DE69315257T2 (de) 1998-05-14
CA2096575A1 (en) 1993-11-22
US5980944A (en) 1999-11-09
GR930100197A (el) 1994-01-31
ES2112387T3 (es) 1998-04-01
US5599577A (en) 1997-02-04
EP0571217A3 (en) 1994-06-01
CA2096575C (en) 2003-05-13
EP0571217B1 (de) 1997-11-19
US5716641A (en) 1998-02-10
US5679376A (en) 1997-10-21

Similar Documents

Publication Publication Date Title
DE69315257T2 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
IL116998A0 (en) Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders
DE122010000031I1 (de) Indolin Verbindungen zur Behandlung von Dysurien
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DE69307509T2 (de) Vorrichtung zur behandlung von herzfehlern
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
DE69600983T2 (de) Kapselpräparate zur Behandlung von Pflanzen
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE59305968D1 (de) Arzneimittel zur erhöhung des testosteronspiegels
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO961226D0 (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO974569D0 (no) Benzamider for behandling av neurodegenerative forstyrrelser
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO982562D0 (no) Sammensetning for behandling av smerte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN